NDC 69336-351

Luvira

Luvira

Luvira is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sterling-knight Pharmaceuticals, Llc. The primary component is Omega-3-acid Ethyl Esters; 12-hydroxyeicosapentaenoic Acid, (12r)-; 4,7,10,13,16,19-docosahexaenoic Acid, (4e,7e,10e,13e,16e,19e)-.

• Product ID: 69336-351_99d7525d-b62e-7f8e-e053-2a95a90a2080
• NDC: 69336-351
• Product Type: Human Prescription Drug
• Proprietary Name: Luvira
• Generic Name: Luvira
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2019-11-07
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: Sterling-Knight Pharmaceuticals, LLC
• Substance Name: OMEGA-3-ACID ETHYL ESTERS; 12-HYDROXYEICOSAPENTAENOIC ACID, (12R)-; 4,7,10,13,16,19-DOCOSAHEXAENOIC ACID, (4E,7E,10E,13E,16E,19E)-
• Active Ingredient Strength: 1220 mg/1; mg/1; mg/1
• Pharm Classes: Fatty Acids, Omega-3 [CS],Omega-3 Fatty Acid [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC SPL Data Element Entries

NDC 69336-351-90 [69336035190]

Luvira CAPSULE

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-11-07
• Marketing End Date: 2020-01-17

Drug Details

Active Ingredients

Ingredient	Strength
OMEGA-3-ACID ETHYL ESTERS	1220 mg/1

Pharmacological Class

• Fatty Acids
• Omega-3 [CS]
• Omega-3 Fatty Acid [EPC]

NDC Crossover Matching brand name "Luvira" or generic name "Luvira"

NDC	Brand Name	Generic Name
69336-349	Luvira	Luvira
69336-351	Luvira	Luvira